This has big implications for how biotech research will fare in the future.
The most widely planted type of biotech crop is engineered to withstand application of an herbicide to kill nearby weeds.
biotech firms also have “Terminator” technology waiting in the wings.
biotech seeds are also quite expensive, two to over four times as much as conventional varieties.
The ruling will have profound effects on medical research, genetic science, and the biotech industry.
NIH has a small RD budget relative to private companies in the drug and biotech industries.
But the whole point of the biotech industry is to blur those boundaries, and Myriad did.
But until yesterday I would have said the same thing about the chances of patent reform in biotech, too.
If biotech crops are not about feeding the world, what is the point?
On the horizon are biotech crops engineered to tolerate multiple—up to seven or more – herbicides.